Revefenacin helps patients with moderate to severe COPD - Video

Published On 2021-11-06T05:02:32+05:30 | Updated On 6 Nov 2021 5:02 AM IST

Overview

Chronic obstructive pulmonary disease (COPD) is a leading cause of death and disability, investigation is essential for better management in both men and women.

A randomized trial by Gary Ferguson and team revealed that nebulized revefenacin produced significant improvements in COPD Assessment Test (CAT) scores in women and men with moderate to very severe COPD, they also revealed significant improvements in St George's Respiratory Questionnaire (SGRQ) scores in women alone when compared with placebo. Maintenance treatment with revefenacin can improve health status of patients with moderate to very severe COPD; however, the effect may be more pronounced in women than men.

For more details, check out the full story on the link below:

Nebulized Revefenacin Improves Health Status Of Patients With Moderate To Very Severe COPD: Study

Speakers

Dr. Nandita Mohan

BDS, MDS( Pedodontics and Preventive Dentistry)

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751